Tabula Rasa Healthcare Might Consider IPO







No pricing details were given in the filing but the offering is valued up to $115 million. The company intends to list on the Nasdaq Global Market TRHC. The underwriters for this offering are Wells Fargo, UBS Investment Bank, Piper Jaffray, Baird and Stifel.

This company is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower health care costs and manage risk.

To read more, visit

Posted in: Investing

Comments are closed.